期刊文献+

踝臂指数在老年下肢外周动脉病患者治疗中的临床意义 被引量:1

Clinical application on the ankle-brachial index in the treatment of peripheral arterial disease in aged patients
原文传递
导出
摘要 【目的】探讨踝臂指数(ankle-brachial index,ABI)在老年下肢外周动脉病患者治疗中应用的临床意义。【方法】老年下肢外周动脉病患者142例,分为2组:A组(单纯药物治疗组)85例,B组(介入治疗+药物治疗组)57例。A组和B组所有病例联合使用瑞舒伐他汀(10 mg/d)、福辛普利钠(10 mg/d)、西洛他唑(200 mg/d)、拜阿司匹林(100 mg/d),连续用药至少12个月。详细记录每位患者的临床资料。并分别于治疗前、治疗后1、3、6、12个月测ABI。【结果】老年下肢外周动脉病患者治疗前ABI<0.90。B组治疗后1、3、6、12个月的ABI较治疗前明显提高(P<0.05)。A组治疗后1、3、6、12个月的ABI与治疗前相比无明显变化(P>0.05)。【结论】ABI是早期诊断老年下肢外周动脉病的无创检查方法,应成为治疗中的常规检查以评估和指导治疗。 [Objective] To investigate the clinical application of ankle-brachial index in the treatment of peripheral arterial disease in aged patients. [Methods] 142 aged patients with peripheral arterial disease were divided into two groups randomly, groupA(n = 85, drug treatment), groupB(n = 57, interventional therapy and drug treatment). All the patients were checked for ABI by automatic analysis system of angiosclerosis. [ Results] ABI 〈 0.90 in old patients with peripheral arterial disease before therapy. ABI was not increased in aged patients with peripheral arterial disease after interventional therapy and drug treatment(P 〈 0.05). ABI is non-increased in old tients with peripheral arterial disease after drug treatment(P 〉 0.05). [Conclusion] ABI is significant in aged patients with peripheral arterial disease who had taken the interventional therapy.
出处 《武警后勤学院学报(医学版)》 CAS 2014年第4期287-289,共3页 Journal of Logistics University of PAP(Medical Sciences)
关键词 踝臂指数 下肢外周动脉病 介入治疗 Ankle-brachial index Peripheral arterial disease Interventional therapy
  • 相关文献

参考文献13

  • 1Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society con- sensus for the management of peripheral arterial disease (TASC II)[J]. Eur J Vasc Endovasc Surg, 2007, 33(Suppl 1): 1- 75. 被引量:1
  • 2Paul M, Rachel P, Kristi R. Relationship between HbAlc level and peripheral arterial disease[J]. Diabetes Care, 2005, 28(7):1981-1987. 被引量:1
  • 3Heather L, Gornlk J, Joshua A. Peripheral arterial disease (PAD)[J]. Circulation, 2005, 111 (5): 169-172. 被引量:1
  • 4Greenland P, Abrams J, Aurigemma GP, et al. Prevention conference V: beyond secondary prevention: identifying the high risk patient for primary prevention:noninvasive tests of atherosclerotic burden:writing group III[J]. Circulation, 2000, 101(1):16-22. 被引量:1
  • 5Ouriel K, Mcdonnell AE, Metz CE, et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular dis- ease[J]. Surgery, 1982, 91(6):686-693. 被引量:1
  • 6杨金刚,王建旗,李觉,等_夕}周动脉疾病诊疗指南[M].上海:同济大学出版社,2006.2,17,42,45. 被引量:1
  • 7胡大一.重视踝臂指数,关注下肢外周动脉病[J].中国医药导刊,2005,7(1):29-29. 被引量:35
  • 8Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease[J]. JAMA, 2006, 295(5):547-553. 被引量:1
  • 9Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral ar- terial disease[J]. J Am Coll Cardiol, 2006, 47(6): 1239-1312. 被引量:1
  • 10Jones SP, Gibson MF, Rimmer DM, et al. Direct vascular and cardioprotective effects of rosuvastain:a new HMG-CoA reduc- tase inhibitor[J]. J Am Coll Cardiol, 2002, 40(6):1172-1178. 被引量:1

共引文献34

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部